+123.8%
MRNA vs RPRX
+52.7%
+71.1%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | RPRX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.2% | +5.6% | +5.5% |
| 7D | -1.1% | -8.4% | +7.3% | +4.0% |
| 30D | +126.1% | -0.6% | +126.8% | +131.1% |
| 3M | +190.0% | +6.4% | +183.6% | +187.7% |
| 6M | +157.2% | +26.6% | +130.6% | +137.0% |
| YTD | +388.2% | +53.8% | +334.4% | +316.0% |
| 1Y | +467.0% | +62.8% | +404.2% | +371.1% |
| 3Y | +36.1% | +118.0% | -82.0% | -0.3% |
| 5Y | -68.0% | +71.2% | -139.2% | -73.9% |
| All | +123.8% | +52.7% | +71.1% | +76.5% |
Cumulative growth
Daily Returns
Daily percentage return beside RPRX.
Daily Out/Under-Performance
Portfolio return minus RPRX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RPRX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded RPRX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling